SCHEMBL2024894

SCHEMBL2024894

O=C(O)[C@H]1CC(O)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3262657 1.00 CYP2D6 (0.60)
SCHEMBL19307 1.00
SCHEMBL22792 1.00
SCHEMBL200243 1.00
SCHEMBL85624 1.00
SCHEMBL1995473 1.00
SCHEMBL6858335 1.00 CYP2D6 (0.60)
SCHEMBL21185 1.00
SCHEMBL21184 1.00
SCHEMBL1696134 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 368 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072741-A1 PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-04-03 WO claimed
CN-119630790-A Novel LRP1 binding peptides 一丸自然美健有限公司 2025-03-14 CN claimed
CN-118984715-A Compositions for the treatment of macular degeneration comprising novel peptides 韩国视角生物株式会社 2024-11-19 CN claimed
CN-118931813-A Microorganism expressing active D-proline reductase and method for producing active D-proline reductase CJ第一制糖株式会社 2024-11-12 CN claimed
EP-4450079-A1 COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE EyebioKorea, Inc. (KR) 2024-10-23 EP claimed
WO-2024197259-A1 TRANSCYTOTIC INTERCELLULAR GELATION ENABLES CELL SPHEROIDS BRANDEIS UNIVERSITY (US) 2024-09-26 WO claimed
CN-118406404-A Circuit board ink-jet printing ink stripping agent and preparation method and application thereof 珠海市板明科技有限公司 2024-07-30 CN claimed
CN-118344408-A Nitrosyl ruthenium complex with hydroxyproline and 5, 7-dichloro-8-hydroxyquinoline as ligands, and preparation method and application thereof 山西大学 2024-07-16 CN claimed
WO-2024029242-A1 NOVEL LRP1-BINDING PEPTIDE 一丸ファルコス株式会社 2024-02-08 WO claimed
WO-2023113300-A1 COMPOSITION FOR TREATING MACULAR DEGENERATION COMPRISING NOVEL PEPTIDE 주식회사 아이바이오코리아 2023-06-22 WO claimed
EP-1304323-A1 PREVENTIVES OR REMEDIES FOR ATOPIC DERMATITIS KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-04-23 EP claimed
US-6497889-B2 CONTAINING HYDROXYPROLINE COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-12-24 US claimed
US-20020009472-A1 Cosmetics KYOWA HAKKO BIO CO., LTD. (JP) 2002-01-24 US claimed
EP-1166767-A2 Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-01-02 EP claimed
EP-1159952-A1 COSMETICS KYOWA HAKKO KOGYO CO., LTD. (JP) 2001-12-05 EP claimed
WO-2001077366-A1 POSITIVE SELECTION METHOD, COMPOUNDS, HOST CELLS AND USES THEREOF CUBIST PHARMACEUTICALS, INC. (US) 2001-10-18 WO claimed
EP-1102860-A1 4-HYDROXYPROLINE EPIMERASE FROM ACINETOBACTER BAUMANNI AND SERRATIA MARCESCENS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2001-05-30 EP claimed
US-6204050-B1 PREPARING STEREOISOMERS; INCUBATE MIXTURE WITH ENZYME AND RECOVER STEREOISOMERS E. I. DU PONT DE NEMOURS AND COMPANY 2001-03-20 US claimed
WO-2000008200-A1 4-HYDROXYPROLINE EPIMERASE FROM $I(ACINETOBACTER BAUMANNI) AND $I(SERRATIA MARCESCENS) E.I. DU PONT DE NEMOURS AND COMPANY (US) 2000-02-17 WO claimed
US-5928933-A SEPARATING RACEMIC MIXTURE BY ENANTIOSELECTIVELY HYDROLYZING THE ESTER OF THE L-ISOMER; CHEMICAL INTERMEDIATE FOR 4-HYDROXYPROLINE E. I. DU PONT DE NEMOURS & COMPANY (US) 1999-07-27 US claimed